Skip to main content
  • 1044 Accesses

Zusammenfassung

Nach einer Mumpsvirusinfektion sind keine Schädigungen für den Embryo/Feten zu erwarten. Da eine Mumpsinfektion schwer verlaufen kann, sollen alle Frauen im gebärfähigen Alter gegen eine Mumpserkrankung geschützt sein. Die Immunitätsfeststellung soll vor der Schwangerschaft durch Kontrolle des Impfausweises erfolgen. Sind zwei Mumps- oder MMR-Impfungen dokumentiert, sind keine weiteren Maßnahmen erforderlich. Eine Antikörperkontrolle wird nicht empfohlen. Fehlende Impfungen sollen vor der Schwangerschaft entsprechend den STIKO-Empfehlungen verabreicht werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 49.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Ammour Y, Faizuloev E, Borisova T, Nikonova A, Dmitriev G et al (2013) Quantification of measles, mumps and rubella viruses using real-time quantitative TaqMan-based RT-PCR assay. J Virol Methods 187(1):57–64

    Article  CAS  PubMed  Google Scholar 

  2. Backhouse JL, Gidding HF, McIntyre PB, Gilbert GL (2006) Evaluation of two enzyme immunoassays for detection of immunoglobulin G antibodies to mumps virus. Clin Vaccine Immunol CVI 13:764–767

    Article  CAS  Google Scholar 

  3. Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E et al (2012) Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med 367:1704–1713

    Article  CAS  PubMed  Google Scholar 

  4. Baumann B, Danon L, Weitz R, Blumensohn R, Schonfeld T, Nitzan M (1982) Unilateral hydrocephalus due to obstruction of the foramen of Monro: another complication of intrauterine mumps infection? Eur J Pediatr 139:158–159

    Article  CAS  PubMed  Google Scholar 

  5. Boddicker JD, Rota PA, Kreman T, Wangeman A, Lowe L et al (2007) Real-time reverse transcription-PCR assay for detection of mumps virus RNA in clinical specimens. J Clin Microbiol 45:2902–2908

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Bolton P, Holt E, Ross A, Hughart N, Guyer B (1998) Estimating vaccination coverage using parental recall, vaccination cards, and medical records. Public Health Rep 113(6):521–526

    CAS  PubMed Central  PubMed  Google Scholar 

  7. Cantell K (1960) Stability of mumps virus at 35 degrees C. Ann Med Exp Biol Fenn 38:309–316

    CAS  PubMed  Google Scholar 

  8. Castilla J, Fernandez Alonso M, Garcia Cenoz M, Martinez Artola V, Inigo Pestana M et al (2009) [Resurgence of mumps in the vaccine era. Factors involved in an outbreak in Navarre, Spain, 2006–2007]. Med Clin (Barc)133(20):777–782

    Google Scholar 

  9. Christenson B, Bottiger M (1990) Methods for screening the naturally acquired and vaccine-induced immunity to the measles virus. Biologicals 18(3):207–211

    Article  CAS  PubMed  Google Scholar 

  10. Cortese MM, Barskey AE, Tegtmeier GE, Zhang C, Ngo L et al (2011) Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity. J Infect Dis 204:1413–1422

    Article  CAS  PubMed  Google Scholar 

  11. Davidkin I, Valle M, Julkunen I (1995) Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up. Vaccine 13:1617–1622

    Article  CAS  PubMed  Google Scholar 

  12. Demicheli V, Jefferson T, Rivetti A, Price D (2005) Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev:CD004407

    Google Scholar 

  13. Demicheli V, Rivetti A, Debalini M G, Di Pietrantonj C (2012) Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev 2:CD004407

    PubMed  Google Scholar 

  14. Dhiman N, Jespersen DJ, Rollins LO, Harring JA, Beito EM, Binnicker MJ (2010) Detection of IgG-class antibodies to measles, mumps, rubella, and varicella-zoster virus using a multiplex bead immunoassay. Diagn Microbiol Infect Dis 67:346–349

    Article  CAS  PubMed  Google Scholar 

  15. Duszczyk E, Krynicka-Czech B, Talarek E, Popielska J (2006) [Mumps – an underestimated disease]. Przegl Epidemiol 60(1):99–104

    PubMed  Google Scholar 

  16. Enders G (1984) [Accidental rubella vaccination in pregnancy]. Dtsch Med Wochenschr 109:1806–1809

    Article  CAS  PubMed  Google Scholar 

  17. Enders M, Biber M, Exler S (2007) [Measles, mumps and rubella virus infection in pregnancy. Possible adverse effects on pregnant women, pregnancy outcome and the fetus]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 50:1393–1398

    Article  CAS  PubMed  Google Scholar 

  18. Enders M, Rist B, Enders G (2005) [Frequency of spontaneous abortion and premature birth after acute mumps infection in pregnancy]. Gynäkol Geburtshilfliche Rundsch 45:39–43

    Article  CAS  PubMed  Google Scholar 

  19. Galazka AM, Robertson SE, Kraigher A (1999) Mumps and mumps vaccine: a global review. Bull World Health Organ 77:3–14

    CAS  PubMed Central  PubMed  Google Scholar 

  20. Garcia AG, Pereira JM, Vidigal N, Lobato YY, Pegado CS, Branco JP (1980) Intrauterine infection with mumps virus. Obstet Gynecol 56(6):756–759

    CAS  PubMed  Google Scholar 

  21. Groenendaal F, Rothbarth PH, van den Anker JN, Spritzer R (1990) Congenital mumps pneumonia: a rare cause of neonatal respiratory distress. Acta Paediatr Scand 79:1252–1254

    Article  CAS  PubMed  Google Scholar 

  22. Gut JP, Lablache C, Behr S, Kirn A (1995) Symptomatic mumps virus reinfections. J Med Virol 45:17–23

    Article  CAS  PubMed  Google Scholar 

  23. Harling R, White JM, Ramsay ME, Macsween KF, van den Bosch C (2005) The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine 23:4070–4074

    Article  CAS  PubMed  Google Scholar 

  24. Hofmann J, Kortung M, Pustowoit B, Faber R, Piskazeck U, Liebert UG (2000) Persistent fetal rubella vaccine virus infection following inadvertent vaccination during early pregnancy. J Med Virol 61:155–158

    Article  CAS  PubMed  Google Scholar 

  25. Hummel KB, Lowe L, Bellini WJ, Rota PA (2006) Development of quantitative gene-specific real-time RT-PCR assays for the detection of measles virus in clinical specimens. J Virol Methods 132:166–173

    Article  CAS  PubMed  Google Scholar 

  26. Jones JF, Ray CG, Fulginiti VA (1980) Perinatal mumps infection. J Pediatr96:912–914

    Google Scholar 

  27. Krause CH, Eastick K, Ogilvie MM (2006) Real-time PCR for mumps diagnosis on clinical specimens–comparison with results of conventional methods of virus detection and nested PCR. J Clin Virol 37:184–189

    Article  CAS  PubMed  Google Scholar 

  28. Kurtz JB, Tomlinson AH, Pearson J (1982) Mumps virus isolated from a fetus. Br Med J 284:471

    Article  CAS  Google Scholar 

  29. Lacour M, Maherzi M, Vienny H, Suter S (1993) Thrombocytopenia in a case of neonatal mumps infection: evidence for further clinical presentations. Eur J Pediatr 152:739–741

    Article  CAS  PubMed  Google Scholar 

  30. Levine HD (1979) Virus myocarditis: a critique of the literature from clinical, electrocardiographic, and pathologic standpoints. Am J Med Sci 277:132–143

    Article  CAS  PubMed  Google Scholar 

  31. Lutwick LI (1996) Postexposure prophylaxis. Infect Dis Clin North Am 10(4):899–915

    Article  CAS  PubMed  Google Scholar 

  32. McLean H, Fiebelkorn AP, Temte JL, Wallace GS (2013) Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013. Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 14:1–34

    Google Scholar 

  33. Nelson GE, Aguon A, Valencia E, Oliva R, Guerrero ML et al (2013) Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control–Guam 2009 to 2010. Pediatr Infect Dis J 32:374–380

    Article  PubMed  Google Scholar 

  34. Nojd J, Tecle T, Samuelsson A, Orvell C (2001) Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine 19:1727–1731

    Article  CAS  PubMed  Google Scholar 

  35. Ornoy A, Tenenbaum A (2006) Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol 21(4):446–457

    Article  CAS  PubMed  Google Scholar 

  36. Pardon F, Vilarino M, Barbero P, Garcia G, Outon E et al (2011) Rubella vaccination of unknowingly pregnant women during 2006 mass campaign in Argentina. J Infect Dis 204 Suppl 2:S745–747

    Article  Google Scholar 

  37. Poethko-Muller C, Mankertz A (2012) Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity. PloS one 7:e42867

    Article  PubMed Central  PubMed  Google Scholar 

  38. Reman O, Freymuth F, Laloum D, Bonte J F (1986) Neonatal respiratory distress due to mumps. Arch Dis Child 61(1):80–81

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Robert Koch-Institut (2012) Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut / Stand: Juli 2012. Epidemiologisches Bulletin 2012

    Google Scholar 

  40. Robert Koch-Institut (2013) Impfquoten bei der Schuleingangsuntersuchung in Deutschland 2011. Epidemiologisches Bulletin 2013

    Google Scholar 

  41. Robert Koch-Institut (2007) Liste der vom Robert Koch-Institut geprüften und anerkannten Desinfektionsmittel und -verfahren. Bundesgesundheitsblatt 50:1335–1356

    Google Scholar 

  42. Robert Koch-Institut (2013) Mumps (Parotitis epidemica), RKI-Ratgeber für Ärzte

    Google Scholar 

  43. Rota JS, Rosen JB, Doll MK, McNall RJ, McGrew M et al (2013) Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in new york city in 2009. Clin Vaccine Immunol : CVI 20:391–396

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  44. Sanz JC, Mosquera Mdel M, Echevarria JE, Fernandez M, Herranz N et al (2006) Sensitivity and specificity of immunoglobulin G titer for the diagnosis of mumps virus in infected patients depending on vaccination status. APMIS 114:788–794

    Article  CAS  PubMed  Google Scholar 

  45. Sato HK, Sanajotta AT, Moraes JC, Andrade JQ, Duarte G et al, Study Group for Effects of Rubella Vaccination During Pregnancy (2011) Rubella vaccination of unknowingly pregnant women: the Sao Paulo experience, 2001. J Infect Dis 204 Suppl 2:S737–744

    Google Scholar 

  46. Siegel M (1973) Congenital malformations following chickenpox, measles, mumps, and hepatitis. Results of a cohort study. JAMA 226:1521–1524

    Article  CAS  PubMed  Google Scholar 

  47. Siegel M, Fuerst HT (1966) Low birth weight and maternal virus diseases. A prospective study of rubella, measles, mumps, chickenpox, and hepatitis. JAMA 197:680–684

    Article  CAS  PubMed  Google Scholar 

  48. Siegel M, Fuerst HT, Peress NS (1966) Comparative fetal mortality in maternal virus diseases. A prospective study on rubella, measles, mumps, chicken pox and hepatitis. N Engl J Med 274:768–771

    Article  CAS  PubMed  Google Scholar 

  49. Soares RC, Siqueira MM, Toscano CM, Maia Mde L, Flannery B et al (2011) Follow-up study of unknowingly pregnant women vaccinated against rubella in Brazil, 2001–2002. J Infect Dis 204 Suppl 2:S729–736

    Article  Google Scholar 

  50. Sterner G, Grandien M (1990) Mumps in pregnancy at term. Scand J Infect Dis Suppl 71:36–38

    CAS  PubMed  Google Scholar 

  51. Takahashi Y, Teranishi A, Yamada Y, Yoshida Y, Hashimoto K et al (1998) A case of congenital mumps infection complicated with persistent pulmonary hypertension. Am J Perinatol 15:409–412

    Article  CAS  PubMed  Google Scholar 

  52. Vandermeulen C, Mathieu R, Geert L R, Pierre VD, Karel H (2007) Long-term persistence of antibodies after one or two doses of MMR-vaccine. Vaccine 25:6672–6676

    Article  PubMed  Google Scholar 

  53. Viola L, Chiaretti A, Castorina M, Tortorolo L, Piastra M et al (1998) Acute hydrocephalus as a consequence of mumps meningoencephalitis. Pediatr Emeg Care 14:212–214

    Article  CAS  Google Scholar 

  54. Weibel RE, Buynak EB, Stokes J Jr, Hilleman MR (1970) Persistence of immunity four years following Jeryl Lynn strain live mumps virus vaccine. Pediatrics 45:821–826

    CAS  PubMed  Google Scholar 

  55. Weil ML, Beard D et al (1948) Purification, pH stability and culture of the mumps virus. J Immunol 60:561–582

    CAS  PubMed  Google Scholar 

  56. White SJ, Boldt KL, Holditch SJ, Poland GA, Jacobson RM (2012) Measles, mumps, and rubella. Clin Obstet Gynecol 55:550–559

    Article  PubMed Central  PubMed  Google Scholar 

  57. WHO (2010) Immunological basis for immunization: Mumps

    Google Scholar 

  58. WHO (2007) Mumps virus vaccines: WHO position paper. Weekly epidemiological record 82:49–60

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Annette Mankertz .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 DVV, GfV

About this chapter

Cite this chapter

Mankertz, A. (2014). Mumps. In: S2k-Leitlinie - Labordiagnostik schwangerschaftsrelevanter Virusinfektionen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43481-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-43481-9_8

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-43480-2

  • Online ISBN: 978-3-662-43481-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics